Cargando…
Novel oligodeoxynucleotide agonists of TLR9 containing N(3)-Me-dC or N(1)-Me-dG modifications
Synthetic oligodeoxynucleotides containing unmethylated CpG motifs activate Toll-Like Receptor 9 (TLR9). Our previous studies have shown the role of hydrogen-bond donor and acceptor groups of cytosine and guanine in the CpG motif and identified synthetic immunostimulatory motifs. In the present stud...
Autores principales: | Putta, Mallikarjuna Reddy, Zhu, FuGang, Li, Yukui, Bhagat, Lakshmi, Cong, YanPing, Kandimalla, Ekambar R., Agrawal, Sudhir |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904100/ https://www.ncbi.nlm.nih.gov/pubmed/16798912 http://dx.doi.org/10.1093/nar/gkl430 |
Ejemplares similares
-
Chemical discrimination between dC and (5Me)dC via their hydroxylamine adducts
por: Münzel, Martin, et al.
Publicado: (2010) -
Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors
por: Agrawal, Sudhir, et al.
Publicado: (2019) -
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
por: Kandimalla, Ekambar R., et al.
Publicado: (2013) -
An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
por: Zhang, Huagang, et al.
Publicado: (2012) -
Synthesis of novel poly(dG)–poly(dG)–poly(dC) triplex structure by Klenow exo(−) fragment of DNA polymerase I
por: Kotlyar, Alexander, et al.
Publicado: (2005)